Inhaled treprostinil for treating pulmonary hypertension with interstitial lung disease [ID6459]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 17 December 2025
Nintedanib for treating fibrosing interstitial lung disease in people aged 6 to 17 [ID6194]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC